Navigation Links
Cell-permeable peptide shows promise for controlling cardiovascular disease
Date:4/17/2013

Philadelphia, PA, April 16, 2013 Atherosclerosis sometimes called "hardening of the arteries" is a leading cause of death and morbidity in Western countries. A cell-permeable peptide containing the NF-ĸB nuclear localization sequence (NLS) shows promise as a potential agent in controlling the development of atherosclerotic disease. This study is published in the May 2013 issue of The American Journal of Pathology.

Atherosclerosis is a chronic inflammatory disease of the arterial and vascular wall. The objective of many therapeutic compounds is to modulate atherogenesis the process that leads to the formation of fatty tissue-containing plaques that stick to the cell wall. Numerous cellular and molecular inflammatory components are involved in the disease process, and uncontrolled activation of pro-inflammatory transcription factors, such as nuclear factor-B (NF-ĸB), plays a significant role. Several NF-ĸB inhibitors are in phase II-III clinical trials against various inflammatory diseases, but most cardiovascular research is still in the preliminary laboratory experimental phase.

Investigators in Spain, the United States, the United Kingdom, and Germany studied the anti-inflammatory and atheroprotective effects of a cell-permeable peptide containing the NF-ĸB NLS. In vitro tests clearly established that NLS peptide blocks the nuclear import of activated NF-ĸB and inhibits NF-ĸB activation in vascular cells. These findings were corroborated in vivo in ApoE knockout mice, an experimental model relevant to human atherosclerosis. In these experiments, the mice were fed a high-fat diet and treated with either NLS peptide or vehicle (control group).

The results showed that systemic administration of NLS peptide reduced the nuclear NF-ĸB activity in vascular smooth muscle cells (VSMCs) and macrophages of aortic plaques of mice. More importantly, NLS peptide inhibited lesion development in mice ei
'/>"/>

Contact: David Sampson
ajpmedia@elsevier.com
215-239-3171
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. A new avenue to better medicines: Metal-peptide complexes
2. Under the right conditions, peptide blocks HIV infection at multiple points along the way
3. Unique peptide could treat cancers, neurological disorders, and infectious diseases
4. Genetic survey of endangered Antarctic blue whales shows surprising diversity
5. University of Houston study shows BP oil spill hurt marshes, but recovery possible
6. Weakness can be an advantage in surviving deadly parasites, a new study shows
7. Study shows unified process of evolution in bacteria and sexual eukaryotes
8. Sexual reproduction brings long-term benefits, study shows
9. UCSB study shows forest insects and diseases arrive in US via imported plants
10. Study shows botanical formula fights prostate cancer
11. Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home ... to their offering. ... different sensing technology than the iPhone 5S, Samsung ... in its product. The Galaxy S5 ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader ... PerformTek biometric technology to industry leaders such as Intel, ... clinically validated, biometric wearable products. These products will be ... Las Vegas . ... accurate, flexible and robust – with the clinical data ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... traditional Dutch landscapes says Dutch researcher Evelien van ... cultural historic value will disappear unless specific agricultural ... both considerable investments and sufficient legislation from the ... possible improvements to rules and policy programmes for ...
... - In pursuing cleaner energy there is such a thing ... be considered too green. In a paper in a special ... (OSA) open-access journal, scientists at the University of California, Berkeley ... researchers explain a way to genetically modify the tiny organisms, ...
... the Fisheries , an archive of oral histories ... and families that rely on them, documents the ... Great Lakes environments and living marine resources. ... Silva of NOAA,s National Marine Fisheries Service have ...
Cached Biology News:Traditional Dutch landscape under threat 2Engineering algae to make fuel instead of sugar 2Human connection to our nation's fisheries comes alive through oral history project 2Human connection to our nation's fisheries comes alive through oral history project 3
(Date:12/24/2014)... , Dec. 23, 2014  NeuroLifeSciences announced today ... in children with attention deficit/hyperactivity disorder published in ... The paper, titled "Pilot Phase 2 ... ( Konofal et al, Drug Des Devel ... shows that mazindol might be an effective, well-tolerated, ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy ... that it has signed a letter of intent ... has developed and patented a nanotechnology-based development platform ... products that enable rapid on-site collection and testing ... and health issues in an immediate, non-invasive and ...
(Date:12/22/2014)... 2014  ( www.competitivehealth.com ) — Competitive Health is ... review and advocacy service, has signed an agreement to ... discount health services marketplace. 63% of Americans ... they expected to pay. As part of an ongoing ... Savings is pleased to offer medical bill review and ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... Mylan Inc. (Nasdaq: MYL ) today announced that ... $1.25 million to support two prominent West Virginia cultural institutions ... West Virginia and the State of West Virginia Division of ... a member of Mylan Charitable Foundation,s board of directors said ...
... Encorium Group, Inc. (Nasdaq:  ENCO), (the "Company"), a ... studies in over 30 countries for many of ... announced that, on October 20, 2010, it received ... "Panel") has determined to delist the Company,s securities ...
... but it has become even harder in recent years the ... slow it down anymore. Reporting their findings in the journal ... closer to understanding why not, and how future treatments can defeat ... drugs, amantadine and rimantadine, are no longer recommended by the CDC ...
Cached Biology Technology:Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions 2Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 2Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 3Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 4Putting a bull's-eye on the flu: Detailing influenza's structure for drug targeting 2
... a new tuning and calibration standard for ... Accumix is a lyophilized 7-peptide standard ... both tuning and calibration of ion trap ... transform mass spectrometers. Direct infusion of ...
Determin interaction of your protein with Echelons lipids...
... N-Dodecyl-N,N-(dimethylammonio)butyrate White crystalline solid. HYGROSCOPIC. ... DDMAU (Cat. No. 252005) but differing in ... efficient for the extraction of mycoplasma membrane ... Purity: ≥98% by TLC. Soluble in ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Biology Products: